Criteo reported a 49% year-over-year decline in GAAP net income to $12 million for Q2 2026, alongside an 11% revenue drop to $428 million. Adjusted EBITDA fell 18% to $73 million, signaling weaker operating results. Following the earnings release, Criteo's shares dropped sharply, prompting a securities investigation into potential misleading statements. Investors who suffered losses may be eligible to seek recovery through legal channels.
BP, a major global energy company, is actively managing its portfolio by potentially selling oil and gas assets in Egypt to Energean and investing in new projects like a Halliburton contract in Brazil's offshore field. This strategic move aims to enh...
Pernod Ricard reported Q4 2026 earnings per share of $0.42 and revenue of $4.90 billion, both surpassing analyst expectations. However, the company faces significant organic sales declines of 14% in the US and 19% in China due to weak consumer demand...
BYD Company Limited is expected to report strong Q2 earnings driven by robust electric vehicle sales and growing exports. The company surpasses Tesla in gross profit margins and delivery volume, highlighting its competitive edge. BYD's strategic focu...
Diodes Incorporated's stock surged 19.27% over the past 30 days, showing strong market momentum despite a recent 12.30% pullback in the last 10 days. This decline has brought the stock to a local low, potentially attracting investors looking for entr...
Alterity Therapeutics Limited is developing experimental drugs ATH434 and PBT2 targeting Parkinson's and Alzheimer's diseases. The consensus analyst price target remains steady at $8.67, reflecting consistent market confidence, while some analysts li...
